Met Life Investment Management, LLC Beyond Spring Inc. Transaction History

Met Life Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 May 17, 2024	BUY	$9.26 - $31.31 $75,681 - $255,896	8,173 New	8,173 $128,000
Q3 2021 Jun 21, 2023	BUY	$9.26 - $31.31 $75,681 - $255,896	8,173 New	8,173 $129 Million
Q3 2020 May 24, 2024	BUY	$9.99 - $16.13 $8,721 - $14,081	873 Added 13.31%	7,433 $98.9 Million
Q3 2020 Jun 26, 2023	BUY	$9.99 - $16.13 $74,255 - $119,894	7,433 New	7,433 $98.9 Million
Q2 2020 May 24, 2024	BUY	$11.21 - $18.15 $73,537 - $119,063	6,560 New	6,560 $98.9 Million

Q2 2020 Jun 26, 2023	BUY	$11.21 - $18.15 $73,537 - $119,063	6,560 New	6,560 $98.9 Million
Q1 2020 Jul 12, 2023	BUY	$9.68 - $18.47 $63,500 - $121,163	6,560 New	6,560 $84 Million

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.9M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.